Marco Chiadò Piat

Marco is currently President, Terumo Pharmaceutical Solutions and Group Manager, Overseas Business Group, Alliance Division, General Hospital Company of Terumo Corporation.
Until early 2017 he served as CEO of Dianax, an early-stage medical technology company active in lab-on-chip, in-vitro diagnostic technologies for point-of-care testing and patient-side applications.
Prior to that he served as Vice President of Strategy, Business Development and New Growth Initiatives with the Cardiac Surgery Business Unit of Sorin Group (now LivaNova). Since joining Sorin Group in 2004.

He received his Laurea in Electronic Engineering from the Polytechnic of Turin, Italy, and his MBA from INSEAD of Fontainebleau, France.


Accetta Rifiuta